iRhythm Technologies, Inc. (IRTC)

86.18 -3.77 (-4.20%) As of 11:30AM EST. Market open.

iRhythm Technologies, Inc.

699 8th Street
Suite 600
San Francisco, CA 94103
United States
415 632 5700
https://www.irhythmtech.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 1,793

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Quentin S. Blackford	President, CEO & Director	2.15M	N/A	1979
Mr. Brice Bobzien CPA	Chief Financial Officer	685.12k	N/A	1979
Dr. Minang P. Turakhia M.D., M.S.	Chief Medical & Scientific Officer and Executive VP of Product Innovation	1M	N/A	1974
Mr. Patrick Michael Murphy J.D.	Chief Business & Legal Officer	1.28M	N/A	1979
Mr. Douglas J. Devine	Executive Advisor	800k	N/A	1970
Mr. Chad M. Patterson	Chief Commercial Officer	771.51k	N/A	1982
Mr. Marc Rosenbaum	Senior VP of Finance & Chief Accounting Officer	N/A	N/A	1972
Mr. Mark J. Day Ph.D.	Chief Technology Officer	718.76k	1.28M	1971
Mr. Daniel G. Wilson	Executive VP of Corporate Development & Investor Relations	670.09k	N/A	1983
Ms. Sumi Shrishrimal	Executive VP & Chief Risk Officer	N/A	N/A	1979

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Corporate governance

iRhythm Technologies, Inc.’s ISS governance QualityScore as of 1 December 2023 is 7. The pillar scores are Audit: 10; Board: 5; Shareholder rights: 6; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.